7,9':7',9-DIEPOXYLIGNANS-PINORESINOL-4,4'-DI-BETA-O-D-GLUCOSIDE
Compound with spectra: 1 NMR
| SpectraBase Compound ID | EqV864atQBw |
|---|---|
| InChI | InChI=1S/C32H42O16/c1-41-19-7-13(3-5-17(19)45-31-27(39)25(37)23(35)21(9-33)47-31)29-15-11-44-30(16(15)12-43-29)14-4-6-18(20(8-14)42-2)46-32-28(40)26(38)24(36)22(10-34)48-32/h3-8,15-16,21-40H,9-12H2,1-2H3/t15-,16-,21+,22+,23+,24+,25-,26-,27+,28+,29+,30+,31+,32+/m1/s1 |
| InChIKey | ZJSJQWDXAYNLNS-VULSHOEPSA-N |
| Mol Weight | 682.7 g/mol |
| Molecular Formula | C32H42O16 |
| Exact Mass | 682.247285 g/mol |
| Enantiomer InChIKey | ZJSJQWDXAYNLNS-FUPWJLLWSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CD3OD |
PHILLYRIN;PHILLYGENIN-4-O-GLUCOPYRANOSIDE
(+)-PINORESINOL-MONO-METHYLETHER-BETA-D-GLUCOPYRANOSIDE
TORTOSIDE-C;5',5''-DEMETHYL-SYRINGARESINOL-4''-O-BETA-D-MONOGLUCOPYRANOSIDE
PHARSYRINGARESINOL;(-)-SYRINGARESINOL-4-O-(6'''-O-ACETYL)-BETA-D-GLUCOPYRANOSIDE
(+/-)-5,5'-DIMETHOXY-4-METHYLLARICIRESINOL 4'-O-beta-D-GLUCOPYRANOSIDE
ICOVMUQEYFVJMG-MJYOTUESSA-N
CONICASIDE;2-BETA-[3,5-DIMETHOXY-4-O-(BETA-D-GLUCOPYRANOSYL)-PHENYL]-3-ALPHA-HYDROXYMETHYL-4-ALPHA-[(4-HYDROXY-3-METHOXYPHENYL)-METHYL]-1-
AEGINEOSIDE;2,3-DIHYDRO-2-(4-HYDROXY-3-METHOXYPHENYL)-3-HYDROXYMETHYL-7-METHOXYBENZOFURAN-5-PROPENOIC-ACID-4-O-BETA-D-GLUCOPYRANOSIDE
SALVADORASIDE
SALVADORASIDE;5,5'-DIMETHOXYLARICIRESINOL-4,4'-BIS-O-BETA-D-GLUCOPYRANOSIDE
| Title | Journal or Book | Year |
|---|---|---|
| Lignans Isolated from Valerian: Identification and Characterization of a New Olivil Derivative with Partial Agonistic Activity at A1 Adenosine Receptors | Journal of Natural Products | 2002 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.